Related by context. All words. (Click for frequent words.) 75 regulated kinase 74 hypoxia inducible factor 74 Janus kinase 74 cell adhesion molecule 74 5 hydroxytryptamine 74 interleukin IL 74 sodium glucose cotransporter 73 selective antagonist 72 reversible inhibitor 72 HER1 72 Janus Kinase 72 IAP inhibitor 72 Angiotensin Converting Enzyme 71 Angiotensin 71 5HT 71 hydroxylase 71 monocyte chemotactic protein 71 mediated apoptosis 71 Novel Oral 71 Interferon gamma 71 Factor Receptor 71 cyclin dependent kinase 71 selective agonist 70 5 HT4 70 mTOR mammalian target 70 serine threonine 70 Tumor necrosis factor 70 Kinase Inhibitor 70 CYP#A# CYP#D# 70 cyclin dependent kinase inhibitor 70 selective inhibition 70 pan HDAC inhibitor 70 receptor partial agonist 70 mu opioid receptor antagonist 70 partial agonist 70 poly ADP ribose polymerase 70 5' monophosphate 70 ,#,# [002] 70 5 HT2A serotonin 69 selective inhibitor 69 dasatinib Sprycel ® 69 phosphate dehydrogenase 69 Protein Kinase 69 glycogen synthase kinase 69 VMAT2 69 cortisol synthesis 69 deoxy 69 Nephrol 69 Factor VEGF 69 Initiate Phase 69 Cyclooxygenase 69 adrenoceptor 69 Tyrosine Kinase Inhibitor 69 cyclooxygenase COX 69 hormone LHRH 69 histone deacetylase 69 intercellular adhesion molecule 69 Randomized Phase 69 J Am Soc 69 selectively binds 69 vapreotide acetate 69 ERK1 2 68 orally administered inhibitor 68 myelofibrosis polycythemia vera 68 receptor subtype 68 SGLT 68 1α 68 CDK inhibitor 68 Protein Kinase C 68 lipoxygenase 68 mineralocorticoid receptor 68 2 inhibitor CYT# 68 polymerase inhibitor 68 metabotropic glutamate receptor 68 methionine aminopeptidase 68 targetters 68 receptor blocker 68 extracellular signal 68 receptor modulators 68 phosphatidylinositol 3 68 Mg Usa 68 novel VDA molecule 68 MEK1 68 ABLYNX 68 cetuximab Erbitux R 68 M1 muscarinic 68 familial amyloidotic polyneuropathy FAP 68 peptidic compound 68 Oral Fingolimod 68 PEGylated Fab fragment 68 Orthop Surg 68 RAF kinase 68 Psychiatry Clin Neurosci 68 dopamine D2 68 peripherally restricted 68 Epidermal Growth Factor Receptor 67 calcitonin gene related 67 Degarelix 67 apoptosis proteins 67 VEGF receptor 67 CYT# potent vascular disrupting 67 agonist compounds 67 cyclooxygenase 67 acyltransferase 67 Antigen Specific 67 5 HT2A receptor 67 enkephalin 67 5 HT2A inverse 67 Cytochrome P# 67 peptide CGRP 67 downregulates 67 non nucleoside inhibitor 67 related apoptosis inducing 67 brivanib 67 receptors PPARs 67 RON Notch 67 sunitinib Sutent ® 67 inverse agonist 67 AAG geldanamycin analog 67 PDGFR 67 Int J Obes Relat 67 TRAIL receptor 67 Macrophage 67 oral Janus kinase 67 protein tyrosine phosphatase 1B 67 R Saizen R 67 Bruton tyrosine kinase 67 Eur Arch 67 Flt3 67 ErbB1 67 alpha folate receptor 67 generation antisense inhibitor 67 investigational humanized monoclonal antibody 67 MET VEGFR2 67 small molecule activator 67 antisense oligonucleotide 67 acyl CoA 67 calcium calmodulin dependent 67 kidney urologic 67 VEGF receptors 67 Pharmacokinetics PK 67 kinase PI3K 67 Liposomal 67 CCL2 67 dasatinib Sprycel 67 receptor modulator 67 prostanoid 67 PDGFR B 67 5 HT6 67 methyltransferase 67 DNA intercalator 67 Overexpression 67 agonistic human 67 monocytic 67 selective phosphodiesterase 67 thrombin receptor 67 selective kinase inhibitor 67 Antiviral Therapy 67 TO AVOID PREGNANCY WHILE 67 receptor kinase 67 Bosutinib 67 pathophysiological effects 67 HCV NS5B polymerase 67 J Am Acad 67 cyclin dependent kinase CDK 67 cytokines IL 67 Mg Uk 67 targeted radiotherapeutic 67 phosphorylates 67 #S #S [003] 67 Aurora kinase 67 novel orally administered 66 dexamethasone Decadron 66 FGFR3 66 treat benign prostatic 66 SensoLyte ® 66 isoenzyme 66 matrix metalloproteases 66 irreversible inhibitor 66 inhibit COX 66 Lymphocytic 66 reversible inhibitors 66 TNF Tumor Necrosis Factor 66 neurokinin 66 receptor blockers 66 Silodosin 66 J Clin 66 humanized interleukin 6 66 Hypoxia Inducible Factor 66 Mol Cell 66 2A receptor agonist 66 mGluR5 negative 66 cyclin dependent kinases 66 peroxisome proliferator activated 66 Commences Phase 66 J Allergy Clin 66 Child Adolesc Psychiatry 66 Suppl. 66 developing Bicifadine serotonin 66 Endothelin 66 Proc Am Soc 66 N acetyl 66 suppl. 66 induces apoptosis 66 V#F mutation 66 novel histone deacetylase 66 Initiated Phase 66 MEK ERK 66 Selective Inhibitor 66 lexidronam injection 66 TNF IL 66 erlotinib Tarceva ® 66 neurokinin 1 66 ADP receptor antagonist 66 diarrhea predominant irritable 66 potential vanilloid 66 TIMP 66 VEGFR2 inhibitor 66 Upregulation 66 cytochrome P 66 mediated inhibition 66 ACC2 66 chemokine receptor 66 P#Y# [001] 66 Pivotal Phase 66 proliferator activated receptor 66 AEG# 66 oral nucleoside analogue 66 p# mitogen activated 66 Abstract Number 66 Nat Clin Pract 66 elastase 66 proprietary polysaccharide 66 highly selective inhibitor 66 factor alpha TNF 66 Aflibercept 66 hyperphosphorylation 66 humanized monoclonal 66 pralatrexate injection folate analogue 66 somatostatin 66 selective modulator 66 R roscovitine CDK cyclin 66 histone deacetylase inhibitor 66 alpha GAL 66 acetylcholine receptor 66 Suppl 66 bevacizumab Avastin R 66 pDC 66 selective immunoproteasome inhibitor 66 Chemokine Receptor 66 gamma agonists 66 N methyl 66 EOquin TM phase 66 NS5B polymerase 66 HDACi 66 glucuronide 66 opioid receptor antagonist 66 muscarinic 66 potent antiproliferative 66 nicotinic acetylcholine receptor 66 TKB# 66 downstream effector 66 HCV SPRINT 66 Prodrug 66 5 HT1A 65 LymphoStat B belimumab 65 Wafer polifeprosan 65 mitogen activated protein kinase 65 AKT inhibitor 65 JAK1 65 Locked Nucleic Acid LNA 65 retinoic acid receptor 65 Enzastaurin 65 essential thrombocythemia ET 65 histone deacetylase HDAC inhibitor 65 receptor tyrosine kinase inhibitor 65 5 HT6 receptor 65 receptor inhibitor 65 Angiotensin converting enzyme 65 Aurora Kinase 65 dehydrogenase 65 NMDA N 65 Phosphorylation 65 PTP 1B 65 ALN HPN 65 pro angiogenic 65 highly selective endothelin 65 Phosphodiesterase 65 interleukin IL -# 65 selective inverse agonist 65 ERalpha 65 Alfacell proprietary ribonuclease 65 vWF 65 serine protease 65 chronic eosinophilic leukemia 65 depsipeptide 65 KSP inhibitor 65 MKC# MT 65 Florbetapir 65 IL #p# 65 ergot derivatives 65 peptibody 65 Reductase 65 kinase pathway 65 selectively inhibits 65 #F AV 65 triggers apoptosis 65 CCR1 65 interleukin IL -6 65 Granulocyte Colony Stimulating Factor 65 anionic backbone 65 N acetylgalactosamine 6 65 ENMD # 65 somatostatin analogue 65 actinin 65 cortisol receptor 65 TRAIL receptors 65 Nedd4 65 Randomized Double blind 65 antiapoptotic 65 HT 1A 65 Androgen Receptor 65 Ovitrelle R Serostim 65 tyrosine kinase receptor 65 oral prodrug 65 Secretase 65 pan histone deacetylase 65 neuronal nitric oxide synthase 65 prolyl 65 Tezampanel 65 TRAIL R2 65 #beta HSD1 65 Am J Clin 65 Fc fusion protein 65 FLT3 65 Nephrol Dial Transplant 65 Xyfid TM 65 potent inhibition 65 liposomal formulation 65 beta 1a 65 β2 65 5 lipoxygenase 65 triciribine phosphate monohydrate 65 FGFR1 65 protein phosphatase 65 DNA methyltransferase inhibitors 65 VEGFR1 65 colony stimulating factor 65 IV FENTORA R 65 myelodysplastic myeloproliferative diseases 65 MTP inhibitor 65 Hepatocellular 65 Bucindolol 65 Phase 2a Clinical Trial 65 benzothiazole 65 AT1R 65 reuptake inhibitor 65 TNF α 65 Glucagon Like Peptide 65 enzyme phosphodiesterase 65 5alpha reductase 65 triiodothyronine 65 Recombinant Human 65 endothelial nitric oxide synthase 65 coronary vasodilation 65 TNFalpha 65 Sapacitabine 65 transient receptor 65 potently inhibit 65 cholesteryl ester transfer 65 Naive Patients 65 complement inhibitor eculizumab 65 Ecallantide 65 5 HT4 receptor 65 serine threonine kinase 65 Meets Primary Endpoint 65 TNF alpha IL 65 Preclinical studies suggest 65 Rho GTPase 65 mineralocorticoid 65 cytochrome P# 65 Abstract Full Text 65 underlying vasculopathy 65 potently inhibited 65 Dose Ranging Study 65 upregulates 65 Am J Obstet 65 uricase 65 suppl #S 65 Fibroblast Growth Factor Receptor 65 PEGylated anti 65 norepinephrine reuptake inhibitor 65 Immunomodulatory 65 PNP inhibitor 65 dual PPAR peroxisome 65 Cyclin Dependent 65 cholecystokinin CCK 65 protein interleukin 65 inhibitor RG# 65 nitric oxide synthase NOS 65 Factor VIIa 65 decarboxylase 65 generation purine nucleoside 65 Azacitidine 65 metalloproteinase 65 deacetylase 65 nitric oxide synthase 65 monocytes macrophages 65 IGF1R 64 myc 64 doi #.#/fj.#-# 64 cis retinoic acid 64 syngeneic 64 small molecule inhibitor 64 estrogen receptor antagonist 64 selective antagonists 64 methyl D aspartate 64 Ann Oncol 64 Custirsen 64 Rigel R# 64 Phase 2b Clinical Trial 64 topical gel formulation 64 PI3K/mTOR 64 NFkB 64 leukemia AML 64 humanized anti 64 Polymerase Inhibitor 64 plasminogen activator inhibitor 64 Phospholipase 64 Anti Tumor 64 Orally administered 64 MEK inhibitor 64 mediated phosphorylation 64 Proteasome 64 antisense inhibitor 64 VIPR2 64 Free Full Text 64 orally bioavailable mimics 64 Nucleoside 64 rhIGFBP 3 64 Curr Opin 64 Pathway Inhibitor 64 PROSTASCINT R 64 Gamma secretase 64 Vascular Endothelial Growth 64 Vascular endothelial growth 64 HMG CoA reductase inhibitors 64 Phospholipase A2 64 G Protein Coupled 64 secretory phospholipase A2 64 Nucleic Acids Res 64 neuronal nicotinic receptor NNR 64 including cyclosporine methotrexate 64 IGF binding 64 2 methoxyestradiol 64 topoisomerase II inhibitor 64 cytidine 64 Signaling Pathway 64 Kahalalide F 64 binds selectively 64 receptor CXCR4 64 immunotoxin 64 Angiotensin II 64 receptor antagonists 64 myocyte enhancer factor 64 Kinase Inhibitors 64 Metab Disord 64 cytokine receptor 64 receptor agonists 64 Fenretinide 64 integrin alpha 64 p# MAPK 64 Zorbtive TM 64 HDAC Inhibitor 64 cystic fibrosis transmembrane conductance 64 Initiates Phase 64 GW# [003] 64 luteinizing hormone releasing 64 c MET 64 SGLT2 64 casein kinase 64 potent inhibitor 64 tyrosine kinase inhibitor 64 LRAT 64 transthyretin TTR 64 mGluR2 NAM 64 abstr 64 RAS MAPK pathway 64 receptor antagonist 64 NFAT 64 HIF biology 64 mGluR2 positive 64 dihydro 64 dependent kinase inhibitor 64 potently inhibits 64 Synthase 64 regulated kinase ERK 64 thyroid hormone receptor 64 Cathepsin B 64 Refractory Hodgkin Lymphoma 64 Tumor Necrosis Factor 64 oral proteasome inhibitor 64 small molecule tyrosine 64 matrix metalloproteinase 64 LPA1 64 avidin 64 non thiazolidinedione TZD 64 sphingosine 1 64 Clusterin 64 monocyte chemoattractant protein 64 Bafetinib 64 Dehydrogenase 64 activin receptor type 64 small molecule thrombopoietin 64 multi kinase inhibitor 64 intracellular accumulation 64 ADL# novel 64 Deadlinepix 64 prostaglandin D2 64 cyclooxygenase 2 64 DG# compounds targeting 64 SGPT 64 tyrosine kinase 64 oral ghrelin agonist 64 K ras mutations 64 PPARgamma 64 Vascular Disrupting Agent 64 PKC inhibitor 64 phospholipase 64 Epidermal Growth Factor 64 Drug Candidate 64 CD# monoclonal antibody 64 humanized therapeutic 64 Receptor Agonist 64 Apolipoprotein E 64 Interferon alfa 64 antibody MT# 64 CD# CD# 64 colorectal carcinoma 64 ps :# 64 neutrophil recruitment 64 iobenguane 64 SIRT2 64 VASCULAR 64 p# alpha [001] 64 adhesion molecule 64 sodium thiosulfate STS 64 fosbretabulin 64 Study Evaluating 64 DNA methyltransferase 64 molecule epidermal 64 hyaluronidase enzyme 64 Progenitor Cells 64 Caveolin 1 64 LPS induced 64 methyl CpG binding 64 J Antimicrob Chemother 64 Tubulin 64 PKC# 64 neuropathic pain metabolic diseases 64 rusalatide acetate 64 Crit Rev 64 Multiple Myeloma MM 64 selective A2A adenosine receptor 64 receptor inhibiting monoclonal 64 nicotinic acetylcholine 64 MGd 64 soluble tumor necrosis 64 5 HT2A 64 Tumour VDA 64 androgen receptor AR 64 Combination REOLYSIN R 64 endothelin receptor 64 Dermatol 64 5 HT2C receptor 64 Modulates 64 drug pipeline TAFA# 64 Enkephalin 64 HIF 1α 64 CD4 monoclonal antibody 64 factor VEGF receptors 64 DGAT 64 guanylate cyclase 64 COX2 64 Incretin 64 targeted antifolate 64 leukocyte adhesion 64 drug zotarolimus 64 JAK2 enzyme 64 Monoclonal Antibody 64 Inhibits 64 dopamine D1 64 R lenalidomide 64 metastatic colorectal 63 Prognostic significance 63 Methylnaltrexone 63 signal transduction inhibitor 63 pyrimidines 63 inhibitor COX 63 sortilin 63 Myeloid 63 acadesine 63 TNF alpha selectively neutralizing 63 Myelofibrosis 63 Receptor Antagonist 63 Phase Ib clinical trials 63 Safinamide 63 Testosterone MDTS R 63 Tie2 63 Histone Deacetylase 63 Peroxisome Proliferator Activated Receptor 63 Commence Phase 63 proto oncogene 63 small molecule activators 63 Cytotoxic 63 Monoclonal 63 Peroxisome proliferator activated 63 GSTP1 63 biased ligand 63 Trial Evaluating 63 gastric carcinogenesis 63 cytochrome p# 63 Neurol 63 Antithrombin 63 factor VIIa 63 Apolipoprotein 63 lymphangiogenesis 63 peroxisomal 63 TRAIL Receptor 63 erythematosus SLE 63 PECAM 63 ^ sup #m 63 DNA demethylating agent 63 Mouse Model 63 thromboxane A2 63 binding protein IGFBP 63 antisense inhibitors 63 methylenetetrahydrofolate reductase 63 gamma secretase inhibitor 63 TGR5 63 B lymphocyte stimulator 63 metformin sulfonylureas 63 enzyme cytochrome 63 vinca alkaloid 63 potent inhibitors 63 metabolic inhibitor 63 Endocrinol 63 Romiplostim 63 potent topoisomerase II 63 Second Pivotal Phase 63 anti CTLA 63 1alpha 63 imatinib Gleevec ® 63 anti amnesic 63 Cannabinor 63 NR2B selective 63 oxidase 63 phosphatidylinositol 63 phosphorylate 63 reductase 63 tubulin polymerization 63 LY# [002] 63 eNOS 63 mertansine 63 Platelet Derived Growth 63 Parathyroid Hormone 63 J Am Coll 63 Cyclooxygenase 2 63 FASEB J. 63 inflammatory PDE 63 novel topoisomerase 63 specific protein tyrosine 63 azacytidine 63 P#X# 63 protein CETP 63 pyrimidine 63 MKC# MKC# PP 63 Adrenergic 63 ERK pathway 63 cytokine IL 63 Ceflatonin R 63 #HT#A 63 selectively inhibited 63 #-# Full Text 63 Cancer Res 63 nicotinic 63 novel synthetic peptide 63 mRNA encoding 63 small molecule chemotherapeutic 63 eotaxin 63 aspartyl 63 Inhibitory 63 cytokine interleukin 63 arsenic trioxide injection 63 TLR9 agonist 63 E2F 63 constitutively active 63 potent vasoconstrictor 63 Anesth 63 vascular disrupting agents 63 alpha melanocyte stimulating 63 radiolabeled 63 LES EXPLOSIFS NORDEX LTEE 63 small molecule glucokinase 63 EGFR HER2 63 LRP6 63 VEGFR 63 enzyme COX 63 prostaglandin E 63 Vidaza ® 63 peripherally acting 63 antibody MAb 63 IFN α 63 Huntingtin 63 l lysine 63 Prolactin 63 accumulate preferentially 63 GLP1 63 transmembrane protein 63 Epothilone D 63 CYP#A# substrate 63 plasma kallikrein inhibitor 63 Pooled Analysis 63 proteasome inhibitor 63 NDTV HINDU # 63 Trandolapril 63 Oncogenic 63 Anthrax Toxin 63 receptor mediated endocytosis 63 deoxy D 63 lysosomal enzyme iduronate 63 MET RET 63 targeting CD# 63 #:#-# [020] 63 annexin 63 Kinoid 63 subtype selective 63 RAF kinase VEGFR 63 PC# cells 63 Complicated Skin 63 cytochrome P# #A# 63 PEG IFN 63 insulin sensitizing 63 eIF4E 63 Completes Patient Enrollment 63 Glycoprotein 63 Phase Ib Clinical Trial 63 A2A receptor 63 hypertrichosis occurred 63 steroidogenesis 63 melatonin receptor 63 Parathyroid hormone 63 Valproic acid 63 HGS ETR1 mapatumumab 63 phospholipase A2 63 receptor tyrosine kinase 63 ABL1 63 D aspartate NMDA receptor 63 von Willebrand Factor 63 Interferon Beta 63 CTAP# Capsules 63 guanylate cyclase C 63 severe NCI Grades 63 GABITRIL 63 Ann Rheum Dis 63 #ß 63 Cytochrome 63 Talabostat 63 immunoconjugate 63 nucleoside analog 63 Thiazolidinediones 63 including eniluracil ADH 63 TRO# 63 peroxidase 63 constitutively activated 63 bFGF 63 XL# anticancer compounds 63 PDE#A 63 Prolongs Survival 63 antiproliferative activity 63 sphingosine kinase 63 FEMALES SHOULD BE ADVISED 63 ribonuclease 63 Cathepsin S 63 Anti Tumor Activity 63 cisplatin resistant 63 aminolevulinic acid 63 Epratuzumab 63 hepatic lipase 63 HSP# inhibitor 63 prostaglandin synthesis 63 Intravitreal 63 ARRY # 63 Systemic Delivery 63 alpha 2A adrenergic 63 preferentially bind 63 % pramoxine HCl 63 Successfully Completes Phase 63 protein secreted 63 Telik logo TELINTRA 63 naturally occurring molecule 63 covalently bound 63 5 6A 6B 63 PATENT FOR 63 HCV protease 63 Polymorphisms 63 PSMA ADC 63 CFTR cystic fibrosis transmembrane 63 vanilloid receptor 63 HER2 HER2 63 Environ Health Perspect 63 N acetylgalactosamine 63 eukaryotic initiation factor 63 Personalized Immunotherapy 63 selective androgen receptor modulator 63 By JENNIFER LEARN 63 multikinase inhibitor 63 Initiates Enrollment 63 Cyclooxygenase Inhibiting Nitric Oxide 63 mda 7 63 Phase #b/#a clinical 63 tumor xenograft models 63 nitric oxide donating prostaglandin 63 Fas ligand 63 cutaneous T 63 Heterozygous 63 phosphoinositide 63 plasmid encoding 63 adrenergic receptors 63 transcriptional repressor 63 Telaprevir VX 63 Monocyte 63 regulator CFTR gene 63 glutathione peroxidase 63 histone deacetylase HDAC inhibitors 63 von Willebrand Factor vWF 63 matrix metalloproteinases MMPs 63 acetylcholinesterase 63 PDE4 inhibitor 62 Preclinical Study 62 Glucocorticoid 62 PT S# 62 Antitumor Activity 62 mGluRs 62 PI3K Akt 62 TLK# 62 Tyrima 62 Fibroblast Growth Factor 62 leukotriene B4 62 S# T# R# 62 muscarinic receptors 62 Ep CAM 62 matrix metalloprotease 62 non alcoholic steatohepatitis 62 Dasatinib 62 hypoxia activated prodrug 62 IFN γ 62 P2Y 62 HT 2A 62 alpha subunit 62 adrenoceptor agonist 62 CHEAP ONLINE PHARMACY LOW 62 investigational pharmacologically unique 62 Dendritic Cells 62 glucokinase 62 metaglidasen 62 NS#/#A protease 62 telomerase therapeutic 62 microRNAs miR 62 CYP# [002] 62 orally dosed 62 inducible nitric oxide synthase 62 polyglutamate 62 Cochrane Database Syst Rev. 62 HOUSE Remains 62 LHRH receptor positive 62 Carcinomas 62 INSPIRE Trial Phase III 62 VEGFR2 62 TIMP 1 62 Histone 62 IGFBP 62 Phase 1b clinical trials 62 OMP #R# 62 mTOR inhibitor 62 Antiviral Activity 62 5 HT1A receptor 62 adenosine A2A 62 negative allosteric modulator 62 vitro pharmacology 62 product platforms AZX# 62 PDX pralatrexate 62 carcinoids originate 62 investigational molecular imaging 62 orally bioavailable 62 mitogen activated protein 62 liposome encapsulated 62 selective adhesion molecule 62 sarcoma melanoma 62 heme oxygenase 1 62 amyloid imaging 62 c MYC 62 e# [005] 62 Monopril 62 CXCR2 62 converting enzyme 62 gefitinib Iressa 62 dihydrochloride 62 serotonin receptor 62 YONDELIS 62 delta gamma agonist 62 UNDIVIDED INTEREST 62 Autoantibodies 62 BMS # 62 glutamyl 62 histone deacetylase inhibitors 62 #-#.#.# [001] 62 Receptor Antagonists 62 See CLINICAL PHARMACOLOGY 62 Squalamine 62 metabotropic glutamate receptors 62 arginine vasopressin AVP 62 Locked Nucleic Acid 62 % hydrocortisone acetate 62 drug monomethyl auristatin 62 Induces Apoptosis 62 dihydrofolate reductase 62 Secondary Hyperparathyroidism 62 AnaSpec Introduces 62 Xanafide 62 selective adenosine 62 MT# MEDI 62 4E BP1 62 IL6 62 protein kinase inhibitor 62 NS5b 62 antifibrotic 62 Vandetanib 62 Strong inducers 62 synthetase 62 laropiprant 62 Eg5 62 Ad5FGF 4 62 Zalypsis R 62 hydroxyphenyl 62 Diovan Exforge Tekturna Zelnorm 62 taxane resistant 62 caveolin 62 IL #E 62 vinblastine 62 CDKs 62 Clin Oncol 62 Hormone Refractory Prostate Cancer 62 Vitro Activity 62 Solazed TM 62 IL 1β 62 somatostatin analog 62 phosphate S1P 62 diphosphate 62 kinase inhibitor 62 activate SIRT1 62 ® lenalidomide 62 small molecule Hedgehog 62 Neurosurg 62 chemokine 62 immune modulator 62 angiopoietin 62 delta opioid receptor 62 deoxyglucose 62 mGluR5 antagonist 62 Tumour Vascular Disrupting Agent 62 Sevelamer 62 alpha 2A 62 Rheumatol 62 GRNOPC1 contains 62 oral Hsp# inhibitor 62 beta arrestin 62 Adenosine A2A 62 Akt activation 62 SAR# [002] 62 Panzem R 62 First Patient Dosed 62 #:#-# [023] 62 novel synthetic PEGylated 62 p# subunit 62 chimeric monoclonal antibody 62 inhibitory receptor 62 Treatment Naïve 62 Files IND 62 Darapladib 62 thiazolides 62 Philadelphia Chromosome Positive 62 1beta 62 VentiRx Pharmaceuticals 62 metastatic neuroendocrine tumors 62 treatment naïve genotype 62 Receives Orphan Drug Designation 62 Initiates Clinical Trial 62 Placebo Controlled Study